The company uses artificial intelligence to detect metabolic patterns from urine samples that indicate prostate cancer.

NEW YORK – Linear Diagnostics is hoping to build a broader test menu for its rapid molecular testing platform to complement its first test for sexually-transmitted infections, the development of which ...

NEW YORK – University of Chicago spinout OrisDx said Tuesday that it has raised $4 million in seed funding and it will use the money to support the launch of its saliva-based molecular test for oral ...

The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.

The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy ...

NEW YORK — Gut microbiome health startup 32 Biosciences said on Tuesday that it has raised $6 million in private funding, which it said will support the development of its first products.

NEW YORK – The US Food and Drug Administration in May granted 510(k) marketing clearances for tests for cancer and precancer disorders, Alzheimer's disease, infectious respiratory diseases, and risk ...

Last week, readers were most interested in a story about the FDA's decision not to appeal a court decision vacating the agency's LDT rule.

The test is the last of three multiplex bloodstream infection panels that the firm has designed for its Liaison Plex molecular testing instrument.